Marian Major

5PUBLICATIONS
11CO-AUTHORS
PharmacogenomicsMajor global burdens of diseaseEpidemiological modellingPreventative health careInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Modeling Highlights the Challenge of Achieving and Maintaining Hepatitis C Virus Micro-Elimination Among People Who Inject Drugs.

|Jan 08, 2025
Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing.

Mary-Ellen Mackesy-Amiti, Alexander Gutfraind, Eric Tatara

|Sep 07, 2022
Enhanced In Vitro and In Vivo Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions.

Sylvie Chabot, Yusra Gimie, Karam Obeid

|Jul 13, 2018
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.

Marian Major, Alexander Gutfraind, Louis Shekhtman

|Jul 22, 2017
Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.

Wendy G Tan, Iryna Zubkova, Alla Kachko

Pageof 1

Frequent Collaborators

2 joint publications

Alexander Gutfraind

2 joint publications

Kimberly Page

2 joint publications

Mary-Ellen Mackesy-Amiti

2 joint publications

Eric Tatara